GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ubiquitech Software Corp (OTCPK:UBQU) » Definitions » Capex-to-Revenue

Ubiquitech Software (Ubiquitech Software) Capex-to-Revenue : 0.00 (As of Aug. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Ubiquitech Software Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Ubiquitech Software's Capital Expenditure for the three months ended in Aug. 2023 was $0.00 Mil. Its Revenue for the three months ended in Aug. 2023 was $0.04 Mil.

Hence, Ubiquitech Software's Capex-to-Revenue for the three months ended in Aug. 2023 was 0.00.


Ubiquitech Software Capex-to-Revenue Historical Data

The historical data trend for Ubiquitech Software's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ubiquitech Software Capex-to-Revenue Chart

Ubiquitech Software Annual Data
Trend Aug08
Capex-to-Revenue
-

Ubiquitech Software Quarterly Data
Nov07 Feb08 May08 Aug08 Nov08 Feb09 May09 Aug09 Nov09 Feb10 May10 Aug22 Aug23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ubiquitech Software's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Ubiquitech Software's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ubiquitech Software's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ubiquitech Software's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Ubiquitech Software's Capex-to-Revenue falls into.



Ubiquitech Software Capex-to-Revenue Calculation

Ubiquitech Software's Capex-to-Revenue for the fiscal year that ended in Aug. 2008 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0
=N/A

Ubiquitech Software's Capex-to-Revenue for the quarter that ended in Aug. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0.042
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ubiquitech Software  (OTCPK:UBQU) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Ubiquitech Software Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Ubiquitech Software's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Ubiquitech Software (Ubiquitech Software) Business Description

Traded in Other Exchanges
N/A
Address
3570 East 12th Avenue, Denver, CO, USA, 80206
Ubiquitech Software Corp is a United States-based multi-media, multi-faceted company. It is engaged in utilizing global internet marketing, direct response television, radio, and traditional marketing to drive traffic to the new industries. The company also focuses on developing Cannabidiol (CBD) Hemp derived products. It owns the proprietary CBD brand CannazALL. The company offers the products through its internally designed and operated web portal www.cannazall.com.
Executives
Young Yuen director, 10 percent owner, officer: CEO/Pres/Secretary/Treasurer 7435 S. EASTERN AVENUE, SUITE 5, LAS VEGAS NV 89123